Abstract
A series of 2-oxiranecarboxylate derivatives were prepared as carnitine palmitoyl transferase I (CPT-I) inhibitors for the development of new antidiabetic agents. The syntheses and biological activities were reported. The most promising derivative (13b) showed 2.5 times more hypoglycemic activity and 2 times lower acute toxicity compared to Etomoxir (3).
| Original language | English |
|---|---|
| Pages (from-to) | 1087-1103 |
| Number of pages | 17 |
| Journal | Heterocycles |
| Volume | 52 |
| Issue number | 3 |
| DOIs | |
| State | Published - 1 Mar 2000 |